RIVA-DAPSONE
RIVA-DAPSONE
Dormant
DIN Number
02489058
Drug Class
Human
Market Date
Aug 21, 2019
Company
HC
laboratoire riva inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02489058
AIG Number0106115001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J04BA02 DAPSONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:16.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
DAPSONEActive
Strength: 100 MG
Monograph: DAPSONE